HUT74614A - Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them - Google Patents
Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them Download PDFInfo
- Publication number
- HUT74614A HUT74614A HU9502468A HU9502468A HUT74614A HU T74614 A HUT74614 A HU T74614A HU 9502468 A HU9502468 A HU 9502468A HU 9502468 A HU9502468 A HU 9502468A HU T74614 A HUT74614 A HU T74614A
- Authority
- HU
- Hungary
- Prior art keywords
- carboxamide
- chloro
- alkyl
- alkoxy
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2192593A | 1993-02-24 | 1993-02-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9502468D0 HU9502468D0 (en) | 1995-10-30 |
HUT74614A true HUT74614A (en) | 1997-01-28 |
Family
ID=21806886
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9502468A HUT74614A (en) | 1993-02-24 | 1994-02-15 | Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0686148A4 (bg) |
JP (1) | JPH08507067A (bg) |
KR (1) | KR960701010A (bg) |
CN (1) | CN1119856A (bg) |
AU (1) | AU6254294A (bg) |
BG (1) | BG62089B1 (bg) |
BR (1) | BR9405737A (bg) |
CA (1) | CA2156420A1 (bg) |
FI (1) | FI953954A0 (bg) |
HU (1) | HUT74614A (bg) |
NO (1) | NO953308L (bg) |
PL (1) | PL175788B1 (bg) |
WO (1) | WO1994019321A1 (bg) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6989263B1 (en) * | 1994-09-23 | 2006-01-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein |
US5811425A (en) * | 1997-03-04 | 1998-09-22 | Abbott Laboratories | Heterocyclic compounds as COX-2 inhibitors |
GB9902455D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
AU7962200A (en) * | 1999-10-29 | 2001-05-14 | Wakunaga Pharmaceutical Co., Ltd | Novel indole derivatives and drugs containing the same as the active ingredient |
BR0208790A (pt) * | 2001-04-11 | 2004-03-30 | Idenix Cayman Ltd | Fenilindoìs para o tratamento de hiv |
SE0201635D0 (sv) * | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
JP2006500355A (ja) | 2002-08-07 | 2006-01-05 | イデニクス(ケイマン)リミテツド | Hiv治療用の置換フェニルインドール類 |
JP4335136B2 (ja) * | 2002-08-09 | 2009-09-30 | メルク エンド カムパニー インコーポレーテッド | チロシンキナーゼ阻害薬 |
AU2003261415C1 (en) * | 2002-08-09 | 2010-01-14 | Merck Sharp & Dohme Corp. | Tyrosine kinase inhibitors |
US7642277B2 (en) | 2002-12-04 | 2010-01-05 | Boehringer Ingelheim International Gmbh | Non-nucleoside reverse transcriptase inhibitors |
SE0301569D0 (sv) | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
AU2004303826A1 (en) | 2003-12-11 | 2005-07-07 | Aventis Pharmaceuticals Inc. | Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase I Epsilon |
DE602005017162D1 (de) | 2004-08-19 | 2009-11-26 | Aventis Pharma Inc | 3-arylthioindol-2-carbonsäureamidderivate und ihre analoge als hemmer von caseinkinase i |
EP1961757B1 (en) | 2004-09-17 | 2010-09-01 | IDENIX Pharmaceuticals, Inc. | Phosphoindoles as HIV inhibitors |
GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
CN102558021A (zh) | 2006-05-26 | 2012-07-11 | 阿斯利康(瑞典)有限公司 | 联芳基或芳基-杂芳基取代的吲哚类化合物 |
ES2488922T3 (es) * | 2006-09-29 | 2014-09-01 | Idenix Pharmaceuticals, Inc. | Fosfoindoles enantiómeramente puros como inhibidores del HIV |
EP2252586A1 (en) * | 2008-02-22 | 2010-11-24 | Irm Llc | Compounds and compositions as modulators of gpr119 activity |
CA2797281A1 (en) * | 2010-05-06 | 2011-11-10 | Merck Sharp & Dohme Corp. | Aza-indole derivatives useful as modulators of faah |
CN106892854B (zh) * | 2015-12-21 | 2019-04-30 | 中国海洋大学 | 一种吲哚生物碱类化合物及其制备方法和用途 |
CN107151223B (zh) * | 2016-03-10 | 2020-03-31 | 中国医学科学院药物研究所 | 一类n-烷基吲哚类化合物在制备抗流感病毒药物中的用途 |
CN106995400B (zh) * | 2017-04-10 | 2019-08-06 | 湘潭大学 | 一种化合物及其盐及其合成方法 |
CN112375027B (zh) * | 2020-12-07 | 2023-03-31 | 中国药科大学 | 吲哚磺酰胺类衍生物及其医药用途 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1935671C3 (de) * | 1968-04-26 | 1975-01-09 | Sumitomo Chemical Co | 2-Aminomethylindole und ihre Salze |
US4255442A (en) * | 1977-08-29 | 1981-03-10 | Schering Corporation | 2-[(Methylsulfinyl)]-3-phenylindoles |
IT1098266B (it) * | 1977-08-29 | 1985-09-07 | Scherico Ltd | 2-sostituti-3-fenilindoli,procedimento per la loro preparazione e per il loro impiego come immunosoppresori |
IL84796A (en) * | 1986-12-17 | 1992-03-29 | Merck Frosst Canada Inc | Substituted n-benzyl-indoles and pharmaceutical compositions containing them |
CA1338012C (en) * | 1987-04-27 | 1996-01-30 | John Michael Mccall | Pharmaceutically active amines |
US5268389A (en) * | 1989-10-16 | 1993-12-07 | Uniroyal Chemical Company, Inc. | Thiocarboxylate ester compounds compositions containing the same |
HUT61296A (en) * | 1989-12-28 | 1992-12-28 | Upjohn Co | Process for producing substituted diaromatic compounds against aids and pharmaceutical compositions comprising same |
WO1993005020A1 (en) * | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
-
1994
- 1994-02-15 JP JP6519119A patent/JPH08507067A/ja active Pending
- 1994-02-15 PL PL94310410A patent/PL175788B1/pl unknown
- 1994-02-15 WO PCT/US1994/001694 patent/WO1994019321A1/en not_active Application Discontinuation
- 1994-02-15 CN CN94191586A patent/CN1119856A/zh active Pending
- 1994-02-15 CA CA002156420A patent/CA2156420A1/en not_active Abandoned
- 1994-02-15 EP EP94909663A patent/EP0686148A4/en not_active Withdrawn
- 1994-02-15 BR BR9405737A patent/BR9405737A/pt not_active Application Discontinuation
- 1994-02-15 HU HU9502468A patent/HUT74614A/hu unknown
- 1994-02-15 AU AU62542/94A patent/AU6254294A/en not_active Abandoned
-
1995
- 1995-08-23 FI FI953954A patent/FI953954A0/fi not_active Application Discontinuation
- 1995-08-23 KR KR1019950703549A patent/KR960701010A/ko not_active Application Discontinuation
- 1995-08-23 NO NO953308A patent/NO953308L/no unknown
- 1995-08-23 BG BG99879A patent/BG62089B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
NO953308D0 (no) | 1995-08-23 |
EP0686148A1 (en) | 1995-12-13 |
WO1994019321A1 (en) | 1994-09-01 |
JPH08507067A (ja) | 1996-07-30 |
FI953954A (fi) | 1995-08-23 |
CA2156420A1 (en) | 1994-09-01 |
KR960701010A (ko) | 1996-02-24 |
NO953308L (no) | 1995-10-24 |
PL175788B1 (pl) | 1999-02-26 |
AU6254294A (en) | 1994-09-14 |
EP0686148A4 (en) | 1996-02-07 |
BR9405737A (pt) | 1995-12-05 |
HU9502468D0 (en) | 1995-10-30 |
BG99879A (bg) | 1996-02-28 |
FI953954A0 (fi) | 1995-08-23 |
BG62089B1 (bg) | 1999-02-26 |
CN1119856A (zh) | 1996-04-03 |
PL310410A1 (en) | 1995-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUT74614A (en) | Nindol derivates suitable for treatment of infection by hiv and pharmaceutical compositions containing them | |
US5527819A (en) | Inhibitors of HIV reverse transcriptase | |
JP4039856B2 (ja) | インテグリン発現阻害剤 | |
JP6903580B2 (ja) | 乳酸脱水素酵素の小分子阻害剤及びその使用方法 | |
CN102105451B (zh) | 葡糖激酶活化剂 | |
AU656615B2 (en) | Inhibitors of HIV reverse transcriptase | |
TWI429642B (zh) | 用於治療與醯基coA-二醯基甘油醯基轉移酶1活性有關聯之病症之化合物,包含其之醫藥組合物及其用途 | |
RU2156251C2 (ru) | Производные имидазопиридинов, способ их получения, фармацевтическая композиция и способ ее получения | |
EP1911755B1 (en) | Benzoimidazole compound capable of inhibiting prostaglandin d synthetase | |
KR20160032241A (ko) | 나트륨 채널의 조절제로서의 설폰아미드 | |
KR20180063145A (ko) | Irak 억제제로서의 헤테로아릴 화합물 및 이의 용도 | |
JP2007508363A (ja) | Crth2アンタゴニスト活性を有する化合物 | |
MXPA05009722A (es) | Inhibidores heterociclicos de cinasa: metodos de uso y sintesis. | |
EA021025B1 (ru) | Соединения, эффективные в качестве ингибиторов ксантиноксидазы, способ их получения и содержащая их фармацевтическая композиция | |
US20040157866A1 (en) | Amide compounds | |
TW201217362A (en) | Heteroaryls and uses thereof | |
JP2008523009A (ja) | 3−(インドリル)−4−アリールマレイミド誘導体および脈管形成阻害剤としてのそれらの使用 | |
JP2007230869A (ja) | アルドステロン受容体拮抗剤 | |
JP4007743B2 (ja) | 血管新生阻害剤 | |
US6610701B2 (en) | Thrombin inhibitors | |
JP2006151810A (ja) | ジヒドロチエノキノリン誘導体及びそれを含む細胞接着阻害剤 | |
JP2023518262A (ja) | Phd阻害剤化合物、組成物、及び使用 | |
KR100767002B1 (ko) | 인테그린 발현 저해제 | |
CA3219167A1 (en) | 3-substituted 1h-pyrrolo[2,3-b]pyridine as grk5 modulators | |
MX2008000657A (es) | Compuesto benzoimidazol capaz de inhibir prostaglandina d sintetasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary prot. cancelled due to non-payment of fee |